Twist Bioscience Corporation TWST Reportable Segment — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's reportable segment — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Twist Bioscience Corporation's reportable segment — D&A?
- Twist Bioscience Corporation (TWST) reported reportable segment — D&A of $6.41M in Q1 2026.
- How has Twist Bioscience Corporation's reportable segment — D&A changed year-over-year?
- Twist Bioscience Corporation's reportable segment — D&A increased by 0.2% year-over-year, from $6.4M to $6.41M.
- What does reportable segment — D&A mean?
- Represents the systematic allocation of the cost of tangible and intangible assets over their useful lives within the reportable segment. It provides insight into the capital intensity of the segment's operations and the ongoing investment in infrastructure.